tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CTNM Stock Latest News

Contineum price target lowered to $14 from $16 at Baird
The FlyContineum price target lowered to $14 from $16 at Baird
12d ago
CTNM
Contineum price target lowered to $22 from $25 at RBC Capital
PremiumThe Fly
Contineum price target lowered to $22 from $25 at RBC Capital
15d ago
CTNM
Contineum Therapeutics: Undervalued Potential in IPF with PIPE-791 Amidst PIPE-307 Setback
PremiumRatings
Contineum Therapeutics: Undervalued Potential in IPF with PIPE-791 Amidst PIPE-307 Setback
15d ago
CTNM
Positive Outlook on Contineum Therapeutics Despite Setbacks, Driven by PIPE-791’s Potential in IPF
PremiumRatings
Positive Outlook on Contineum Therapeutics Despite Setbacks, Driven by PIPE-791’s Potential in IPF
15d ago
CTNM
Closing Bell Movers: Elastic down 12% despite beat and raise
PremiumThe Fly
Closing Bell Movers: Elastic down 12% despite beat and raise
16d ago
MU
GAP
Optimistic Buy Rating for Contineum Therapeutics Amid Promising PIPE-791 Developments
PremiumRatingsOptimistic Buy Rating for Contineum Therapeutics Amid Promising PIPE-791 Developments
16d ago
CTNM
Contineum Therapeutics Reports Phase 2 Trial Results
Premium
Company Announcements
Contineum Therapeutics Reports Phase 2 Trial Results
16d ago
8K
CTNM
Contineum Therapeutics Inc trading resumes
Premium
The Fly
Contineum Therapeutics Inc trading resumes
16d ago
CTNM
Contineum Phase 2 VISTA trial did not meet primary, secondary endpoints
PremiumThe Fly
Contineum Phase 2 VISTA trial did not meet primary, secondary endpoints
16d ago
CTNM
Contineum Therapeutics Inc trading halted, news pending
PremiumThe Fly
Contineum Therapeutics Inc trading halted, news pending
16d ago
CTNM
Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities
PremiumRatings
Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities
1M ago
CTNM
Contineum Therapeutics Reports Increased R&D Investment Amid Losses
PremiumCompany Announcements
Contineum Therapeutics Reports Increased R&D Investment Amid Losses
1M ago
CTNM
Contineum reports Q3 EPS (45c), consensus (46c)
PremiumThe FlyContineum reports Q3 EPS (45c), consensus (46c)
1M ago
CTNM
Premium
Ratings
Buy Rating for Contineum Therapeutics Driven by Strategic Positioning and Enhanced Efficacy in IPF Market
2M ago
CTNM
Leerink bullish on Contineum, initiates with an Outperform
Premium
The Fly
Leerink bullish on Contineum, initiates with an Outperform
2M ago
BMY
CTNM
Contineum initiated with an Outperform at Leerink
PremiumThe Fly
Contineum initiated with an Outperform at Leerink
2M ago
CTNM
PremiumRatings
Promising Potential of PIPE-791: Buy Rating for Contineum Therapeutics Amid Positive Phase 1b Results
3M ago
CTNM
PremiumRatings
Buy Rating for Contineum Therapeutics’ PIPE-791: Promising Phase 1b Results and Competitive Edge
3M ago
CTNM
Contineum announces topline data from PIPE-791 trial
PremiumThe Fly
Contineum announces topline data from PIPE-791 trial
3M ago
CTNM
PremiumCompany AnnouncementsContineum Therapeutics Announces Positive Phase 1b Trial Results
3M ago
8K
CTNM
3 Best Stocks to Buy Now, 8/19/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 8/19/2025, According to Top Analysts
4M ago
WIX
CTNM
Premium
Company Announcements
Contineum Therapeutics Reports Q2 2025 Results and Clinical Progress
4M ago
CTNM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >